Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Minor wording updates in the Publications section (describing PubMed auto-fill) and a revision tag change from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:33.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A government funding notice banner was removed from the page. The study details, status, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:27:17.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content remains focused on the AVANOVA study details (NCT02354131), including design, eligibility, and locations.
    Difference
    0.3%
    Check dated 2025-11-03T21:30:29.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    3%
    Check dated 2025-10-06T07:53:37.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Added a new version tag (v3.1.0). - Removed a specific resource (Ovarian cancer) and an older revision (v3.0.2).
    Difference
    0.4%
    Check dated 2025-09-29T04:24:51.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the 'Back to Top' link; overall, a minor UI/version update with no impact on core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-14T22:08:57.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.